Impact of [68Ga]PSMA-PET/CT using PRIMARY and miPSMA Expression Scores on Clinical Decision-Making for ePLND in Staging of lntermediate-Risk Prostate Cancer patients

Florian Szigeti; Alireza Safarian; Christian Pirich; Moshen Beheshti

Impact of [68Ga]PSMA-PET/CT using PRIMARY and miPSMA Expression Scores on Clinical Decision-Making for ePLND in Staging of lntermediate-Risk Prostate Cancer patients

Florian Szigeti (Contributor)
, Alireza Safarian
, Christian Pirich
, Moshen Beheshti^*

^*Corresponding author for this work

Division of Molecular lmaging and Theranostics, Department of Nuclear Medicine, University Hospital, Paracelsus Medical University, Salzburg

Research output: Contribution to conference › Abstract

Original language	English
Publication status	Published - 29 Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Classification according to Österreichische Systematik der Wissenschaftszweige (ÖFOS 2012)

302070 Radiodiagnostics

Applied Research Level (ARL)

ARL Level 8 - Qualified principle with proof of functionality in use

Research focus/foci

Applied Health Innovation

Cite this

@conference{5e061e6934d747cd9d86216ee9cbcb87,

title = "Impact of [68Ga]PSMA-PET/CT using PRIMARY and miPSMA Expression Scores on Clinical Decision-Making for ePLND in Staging of lntermediate-Risk Prostate Cancer patients",

keywords = "[68Ga]PSMA-PET/CT, Prostate Cancer",

author = "Florian Szigeti and Alireza Safarian and Christian Pirich and Moshen Beheshti",

year = "2025",

month = apr,

day = "29",

language = "English",

}

Impact of [68Ga]PSMA-PET/CT using PRIMARY and miPSMA Expression Scores on Clinical Decision-Making for ePLND in Staging of lntermediate-Risk Prostate Cancer patients

UN SDGs

Classification according to Österreichische Systematik der Wissenschaftszweige (ÖFOS 2012)

Applied Research Level (ARL)

Research focus/foci

Other files and links

Cite this